Ceftin and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Ceftin (cefuroxime axetil), especially for people who are female, 60+ old, also take Celebrex, and have Primary immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Otitis when taking Ceftin. It is created by eHealthMe based on reports of 4,099 people who have side effects when taking Ceftin from the FDA, and is updated regularly.

What is Ceftin?

Ceftin has active ingredients of cefuroxime axetil. It is often used in sinusitis. eHealthMe is studying from 4,333 Ceftin users. Check the latest studies of Ceftin.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,416 drugs and 1,832 conditions by eHealthMe. Check the latest studies of Otitis.

On Jul, 14, 2026

4,099 people reported to have side effects when taking Ceftin.
Among them, 26 people (0.63%) have Otitis.

Among these 26 people:

What is the gender of people who have Otitis when taking Ceftin? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Otitis when taking Ceftin? *

What are other drugs people take besides Ceftin? *

What are other side effects people have besides Otitis? *

Joint Pain: 14 people, 53.85%
Upper Respiratory Tract Infection: 13 people, 50.00%
Depression: 12 people, 46.15%
Stress And Anxiety: 11 people, 42.31%
Injury: 11 people, 42.31%
Pain: 11 people, 42.31%
Head Injury: 11 people, 42.31%
Disability: 11 people, 42.31%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 11 people, 42.31%
Thrombocytopenia (decrease of platelets in blood): 11 people, 42.31%

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 3 people, 11.54%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.69%
Hypoglobulinaemia (deficiency of globulin in the bloodstream): 2 people, 7.69%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.85%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 3.85%
Immune System Disorder: 1 person, 3.85%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 3.85%
Depression: 1 person, 3.85%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.85%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftin and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftin:

Ceftin (4,333 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Ceftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,416 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,832 conditions)

Related publications that referenced our studies

Sahoo HB, Rath B, Behera JP, Moharana CS, "Cefuroxime axetil associated oral eruption: A case report", Apollo Medicine, 2016 Jun .
Sahoo HB, Rath B, Behera JP, Moharana CS, "Cefuroxime axetil associated oral eruption: A case report", Apollo Medicine, 2016 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime axetil (the active ingredients of Ceftin) and Ceftin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.